Published in Obstet Gynecol on January 01, 1994
Complete hydatidiform mole presenting as a placenta accreta in a twin pregnancy with a coexisting normal fetus: case report. Case Rep Obstet Gynecol (2012) 1.02
Dizygotic twin pregnancy with a complete hydatidiform mole and a coexisting viable fetus. Iran J Radiol (2011) 1.02
Twin pregnancy with a living fetus and coexisting complete hydatidiform mole. Ulster Med J (2000) 0.93
Two cases of complete hydatidiform mole and coexistent live fetus. J Prenat Med (2013) 0.91
Twin Pregnancy with a Complete Hydatidiform Mole and a Coexisting Live Fetus: Rare entity. Sultan Qaboos Univ Med J (2015) 0.87
Termination of twin pregnancies with hydatidiform moles: a case series of four patients. Iran J Public Health (2014) 0.78
Twin pregnancy with Hydatidiform Mole and Co-existent Live Fetus: Lessons Learnt. Malays J Med Sci (2015) 0.75
[Twin pregnancy involving a molar pregnancy and living fetus with progression to invasive mole: about two cases]. Pan Afr Med J (2015) 0.75
Viable triplet pregnancy coexisting with a complete molar pregnancy. Clin Case Rep (2016) 0.75
Medical termination of a partial hydatidiform mole and coexisting fetus during the second trimester: A case report. Oncol Lett (2015) 0.75
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med (1983) 8.82
Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst (2001) 2.83
Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet (2001) 2.09
Pseudobowenoid change of the vulva: a histologic variant of untreated condylata acuminatum. Mod Pathol (1996) 2.04
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med (1991) 1.99
Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol (2001) 1.96
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res (1993) 1.89
Chorionic tumors. N Engl J Med (1996) 1.87
SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol (2001) 1.76
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst (1998) 1.64
Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res (2001) 1.61
Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer (2011) 1.56
Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res (1995) 1.56
Five years' experience with the prevention of trophoblastic tumors by the prophylactic use of chemotherapy in patients with molar pregnancy. Clin Obstet Gynecol (1970) 1.53
Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol (1993) 1.52
Should atypical squamous cells of undetermined significance (ASCUS) be subcategorized? Accuracy analysis of Papanicolaou smears using receiver operating characteristic curves and implications for the ASCUS/squamous intraepithelial lesion ratio. Am J Clin Pathol (2001) 1.51
Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol (1994) 1.48
Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol (2000) 1.48
The changing clinical presentation of complete molar pregnancy. Obstet Gynecol (1995) 1.47
Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor. Gynecol Oncol (1999) 1.44
Transcervical expulsion of a fibroid as a result of uterine artery embolization for leiomyomata. J Vasc Interv Radiol (1999) 1.42
SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene (1996) 1.42
Pseudoinvasion of vascular spaces: report of an artifact caused by cervical lidocaine injection prior to loop diathermy. Hum Pathol (1994) 1.42
Tamoxifen-induced uterine abnormalities: the role of imaging. Radiology (2000) 1.42
Adenocarcinoma in situ in cervical smears with a small cell (endometrioid) pattern: distinction from cells directly sampled from the upper endocervical canal or lower segment of the endometrium. Am J Clin Pathol (1998) 1.40
Atypical immature metaplastic-like proliferations of the cervix: diagnostic reproducibility and viral (HPV) correlates. Hum Pathol (1999) 1.39
Laparoscopy in the diagnosis and management of pelvic pain in adolescents. J Reprod Med (1980) 1.37
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol (2000) 1.35
Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer (1975) 1.27
DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene (1998) 1.26
Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol (2001) 1.26
The chemotherapy of gestational trophoblastic disease: principles of clinical management. JAMA (1972) 1.21
DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene (1998) 1.20
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol (2000) 1.19
Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol (1996) 1.17
Invasive cervical carcinoma in young women. Gynecol Oncol (1979) 1.17
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene (1996) 1.16
Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses. J Reprod Med (1994) 1.12
Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res (2001) 1.11
The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. Gynecol Oncol (2001) 1.10
Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol (1986) 1.09
Central nervous system involvement by ovarian carcinoma: a complication of prolonged survivial with metastatic disease. Cancer (1978) 1.09
A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol (1992) 1.07
Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med (1998) 1.07
A new human topoisomerase III that interacts with SGS1 protein. Nucleic Acids Res (1999) 1.05
Isolated congenital renal tubular immaturity in siblings. Hum Pathol (1986) 1.04
Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol (1989) 1.02
Gestational trophoblastic disease of the fallopian tube. J Reprod Med (1991) 1.02
Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res (1995) 1.02
The clinical application of a specific radioimmunoassay for human chorionic gondotropin in trophoblastic and nontrophoblastic tumors. Surg Gynecol Obstet (1974) 1.02
Prophylactic chemotherapy of patients with molar pregnancy. Obstet Gynecol (1971) 1.01
Natural history of partial molar pregnancy. Obstet Gynecol (1985) 1.01
Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol (1984) 1.01
Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol (1994) 1.00
Diagnosis and management of the primary hydatidiform mole. Obstet Gynecol Clin North Am (1988) 0.99
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion. Int J Gynecol Cancer (2007) 0.98
Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene (1997) 0.98
Current management of complete and partial molar pregnancy. J Reprod Med (1994) 0.98
Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol (1987) 0.98
Peritoneal inclusion cysts: ovarian fluid in peritoneal adhesions. Radiology (1988) 0.97
Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol (1993) 0.97
The role of thoracotomy in the management of patients with chest metastases from gestational trophoblastic disease. J Thorac Cardiovasc Surg (1972) 0.97
Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res (1996) 0.96
Adolescent endometriosis. J Adolesc Health Care (1980) 0.96
C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors. Oncogene (2012) 0.96
Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar. J Immunol (1985) 0.96
Immunoreactivity of S100 protein, alpha-1-antitrypsin, and CD68 in adult and congenital granular cell tumors. Mod Pathol (1996) 0.95
Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol (1991) 0.95
Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol (2000) 0.95
Fetal vasculitis in preterm newborns: interrelationships, modifiers, and antecedents. Placenta (2004) 0.95
Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol (1995) 0.94
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol (2000) 0.94
Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management. Major Probl Obstet Gynecol (1982) 0.94